Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01675167 · ClinicalTrials.gov registry record · Phase 3
Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects
A Phase 3 study of Low Back Pain, sponsored by BioDelivery Sciences International.
- Completed
- Registry status
- Phase 3
- Development phase
- 815
- Enrollment target
- 20
- Study locations
NCT01675167 is a Phase 3 study of Low Back Pain that has completed, run by BioDelivery Sciences International. The registered enrollment target is 815 participants, above the 497-participant average among 122 other Low Back Pain trials with a reported enrollment target (64% higher). The trial reports 20 study locations across 5 states.
The verdict
NCT01675167, a Phase 3 study of Low Back Pain, has completed, sponsored by BioDelivery Sciences International.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 815 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of the study is to determine if buprenorphine hydrochloride (HCl) buccal film is effective in treating opioid-experienced subjects, with moderate to severe chronic low back pain (CLBP), who require continuous around-the-clock (ATC) pain relief for an extended period of time.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Buprenorphine
Study Locations (20)
Florida
- Century Clinic Research - Daytona Beach
- Avail Clinical Research, LLC - DeLand
- Florida Health Center - Fort Lauderdale
- Eastern Research, Inc. - Hialeah
- Florida Institute of Medical Research - Jacksonville
- Drug Study Institute - Jupiter
- Health Awareness, Inc. - Jupiter
- FPA Clinical Research - Kissimmee
- Try Research, Inc. - Maitland
- NEMA Research, Inc. - Naples
California
- Global Research - Anaheim
- Catalina Research Institute, LLC - Chino
- Synergy Clinical Research Center of Escondido - Escondido
- RX Clinical Research, Inc. - Garden Grove
- Adam D. Karns, MD - Los Angeles
Alabama
- Parkway Medical Center - Birmingham
- Haleyville Clinical Research LLC - Haleyville
- Horizon Research Group. Inc / Alabama Orthopedice - Mobile
Arizona
- Arizona Research Center - Phoenix
Connecticut
- Stamford Therapeutics Consortium - Stamford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 815 participants |
| Start Date | 2012-09 |
| Est. Completion | 2014-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01675167
The ClinicalTrials.gov registry entry for NCT01675167 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 815 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 497-participant average among 122 other Low Back Pain trials with a reported enrollment target (64% higher). The listed sponsor is BioDelivery Sciences International, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01675167 reports 20 study locations spanning 5 distinct geographic areas - top geographies include Florida, California, Alabama.
Frequently Asked Questions
What is clinical trial NCT01675167 about?
NCT01675167 is a clinical study titled "Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects". The purpose of the study is to determine if buprenorphine hydrochloride (HCl) buccal film is effective in treating opioid-experienced subjects, with moderate to severe chronic low back pain (CLBP), who require continuous around-the-clock (ATC) pain relief for an extended period of time.
What is the current status of trial NCT01675167?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 815 participants. The study started on 2012-09. Estimated completion is 2014-06.
What conditions does trial NCT01675167 study?
This clinical trial studies the following conditions: Low Back Pain.
What interventions are being tested in trial NCT01675167?
The interventions under investigation include: Placebo (DRUG), Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT01675167?
This trial is sponsored by BioDelivery Sciences International, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01675167 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nonpharmacologic Pain Management in FQHC Primary Care Clinics
RECRUITING · Phase 3
-
The Use of Methylsulfonylmethane (MSM) in the Treatment of Low Back Pain
COMPLETED · Phase 3
-
Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
COMPLETED · Phase 3
-
Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain
COMPLETED · Phase 3
-
Osteopathic Health Outcomes in Chronic Low Back Pain (OSTEOPATHIC) Trial
COMPLETED · Phase 3
-
Acupuncture Analgesia in Relation to Psychiatric Comorbidity
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.